PetMed Express (NASDAQ:PETS) Share Price Passes Above Two Hundred Day Moving Average – Should You Sell?

PetMed Express, Inc. (NASDAQ:PETS) shares crossed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $2.82 and traded as high as $3.16. PetMed Express shares last traded at $2.93, with a volume of 261,253 shares trading hands.

Wall Street Analysts Forecast Growth

Several analysts have commented on the stock. Weiss Ratings reissued a “sell (e+)” rating on shares of PetMed Express in a research report on Monday, December 29th. Wall Street Zen lowered shares of PetMed Express from a “hold” rating to a “sell” rating in a research note on Saturday, October 18th. One analyst has rated the stock with a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Sell” and an average target price of $3.20.

PetMed Express Price Performance

The stock’s 50 day moving average price is $3.19 and its two-hundred day moving average price is $2.82. The firm has a market capitalization of $68.05 million, a price-to-earnings ratio of -1.02 and a beta of 0.70.

PetMed Express (NASDAQ:PETS) last announced its earnings results on Thursday, February 5th. The company reported ($0.50) EPS for the quarter, missing the consensus estimate of ($0.06) by ($0.44). The firm had revenue of $40.66 million during the quarter, compared to the consensus estimate of $54.04 million. PetMed Express had a negative return on equity of 70.81% and a negative net margin of 35.51%. As a group, equities research analysts anticipate that PetMed Express, Inc. will post 0.19 EPS for the current fiscal year.

Institutional Trading of PetMed Express

Several hedge funds have recently added to or reduced their stakes in the business. Steel Partners Holdings L.P. acquired a new position in shares of PetMed Express during the fourth quarter worth approximately $620,000. UMB Bank n.a. bought a new position in PetMed Express during the fourth quarter worth $192,000. State Street Corp raised its stake in PetMed Express by 7.8% during the 4th quarter. State Street Corp now owns 105,173 shares of the company’s stock valued at $337,000 after purchasing an additional 7,600 shares during the last quarter. Gagnon Securities LLC boosted its holdings in PetMed Express by 77.5% in the 4th quarter. Gagnon Securities LLC now owns 42,328 shares of the company’s stock valued at $135,000 after purchasing an additional 18,487 shares during the period. Finally, Federated Hermes Inc. grew its position in PetMed Express by 30.1% in the 4th quarter. Federated Hermes Inc. now owns 627,743 shares of the company’s stock worth $2,009,000 after purchasing an additional 145,357 shares during the last quarter. Institutional investors own 73.33% of the company’s stock.

PetMed Express Company Profile

PetMed Express, Inc operates as an online and catalog-based pet pharmacy and retail supplier under the 1-800-PetMeds brand name. The company distributes prescription and non‐prescription medications, nutritional supplements, flea and tick control products, and a range of pet health supplies directly to consumers. Through its licensed veterinary pharmacy in Delray Beach, Florida, PetMed Express fills orders for dogs, cats and other companion animals, offering both branded and generic products alongside its own private‐label formulations.

Founded in 1996 by Marc Puleo, PetMed Express built its business on the premise of convenience and cost savings for pet owners seeking reliable access to veterinary medications.